Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer

Langenbeck's Archives of Surgery

Volumn 391, Issue 2, 2006, Pages 124-129

  Tentes, Antonios Apostolos K ^a   Markakidis, Sotirios K ^a   Karanikiotis, Charisios ^a   Fiska, Aliki ^b   Tentes, Ioannis K ^b   Manolopoulos, Vangelis G ^b   Dimitriou, Thespis ^b  

^a Didimotichon General Hospital   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Curative gastrectomy; Gastric cancer; Intraarterial chemotherapy

Indexed keywords

DOXORUBICIN; FLUOROURACIL; MITOMYCIN C;

ADULT; ADVANCED CANCER; AGED; ANALYTIC METHOD; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; EVALUATION; FEMALE; GASTRECTOMY; HEART FAILURE; HISTOPATHOLOGY; HUMAN; ILEUS; INTERMETHOD COMPARISON; LEUKOPENIA; MALE; MEDICAL RECORD; NEUTROPENIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; STOMACH CANCER; SURVIVAL RATE; TREATMENT FAILURE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DOXORUBICIN; FEMALE; FLUOROURACIL; GASTRECTOMY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33645767204     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-006-0022-z     Document Type: Article

References (33)

1. Akoh J, and Mc Intyre I (1992) Improving survival in gastric cancer: review of 5-year survival rates in English language publication from 1970. Br J Surg 79:293-299
2. Hermans J, Bonenkamp JJ, Boon MC, Ohyama S, Sasako M, van de Velde CJ (1993) Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 11:1441-1447
3. Hallisey MT, Dunn JA, Ward CL, Allum WH (1994) The second British stomach cancer group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 343:1309-1312
4. Wanebo H, Kennedy B, Chmiel J, Steele G Jr, Winchester D, Osteen R (1993) Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg 218:583-593
5. Mac Donald JS (2005) Role of postoperative chemoradiation in resected gastric cancer. J Surg Oncol 90:166-170
6. Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418-425
7. Siewert J, Bottcher K, Roder J, Busch R, Hermanek P, Meyer H, and the German Gastric Carcinoma Study Group (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80:1015-1018
8. Pacelli F, Doglietto F, Bellantine R, Alfieri S, Sgadari A, Crucitti F (1993) Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 80:1153-1156
9. Jatzko G, Lisborg P, Denk H, Klimpfinger M, Stettner H (1995) A 10-year experience with Japanese type radical lymph node dissection for gastric cancer outside of Japan. Cancer 76:1302-1312
10. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized trial. Surgical Cooperative Group. Br J Cancer 79:1522-1530
11. Hartgrink HH, van de Velde CJH, putter H, Bonenkamp JJ, Kranenbarg EK, Songun I, Welvaart K, van Kriecken JHJM, Plukker JTM, van Elk PJ, Obertop H, Gouma DJ, van Lanshot JJB, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial. J Clin Oncol 22:2069-2077
12. Gunderson L, Sosin H (1992) Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look), clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8:1-11
13. Bruckner H, Stablein D (1983) Sites of treatment failure: gastrointestinal tumor study group analyses of gastric, pancreatic and colonic trials. Cancer Treat Symp 2:199-202
14. Wils J, Meyer H, Wilke H (1994) Current status and future directions in the treatment of localized gastric cancer. Ann Oncol 5(Suppl 3):69-71
15. Kemeny N, Fata F (2001) Hepatic arterial chemotherapy. Lancet Oncol 2:418-428
16. Tsukamoto S, Ishikawa S, Tsutsumi M, Nakajima K, Sugahara S (2002) An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma. Scand J Urol Nephrol 36:339-343
17. 2 gastrectomy for advanced gastric cancer. Reg Cancer Treat 9:107-109
18. Stephens F (1988) Management of gastric cancer with regional chemotherapy preceding gastrectomy - 5 year survival results. Reg Cancer Treat 1:80-82
19. Takahashi Y, Mai M, Fujimoto T, Ohta H, Ogino T (1989) Preventive hepatic arterial infusion in high risk cases of liver metastasis from gastric cancer. Gan To Kagaku Ryoho 18:2756-2759
20. Stephens F, Adams B, Crea P (1986) Intra-arterial chemotherapy given preoperatively in the management of carcinoma of the stomach. Surg Gynecol Obstet 162:370-374
21. Papachristou E, Link KH, Schoenberg MH (2003) Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer. Anticancer Res 23:831-834
22. Link KH, Gansauge F, Gorich J, Leder GH, Rilinger N, Beger HG (1997) Palliative and adjuvant regional chemotherapy in pancreatic cancer. Eur J Surg Oncol 23:409-411
23. Japanese Classification of Gastric Carcinoma (1995) Japanese Research Society for Gastric Cancer. Kanehara, Tokyo (1st English edition)
24. American Joint Committee on Cancer (1992) Manual for Staging of Cancer, 4th edn. Lippincott, Philadelphia
25. Ensminger W (2002) Intrahepatic arterial infusion of chemotherapy: pharmacologic principles. Semin Oncol 29:119-125
26. Howell J, Warren H, Anderson J, Kerr D, McArdle C (1999) Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer. Eur J Surg 165:652-658
27. Stephens F, Harker G, Crea R (1980) The intraarterial infusion of chemotheraputic agents as "basal" treatment of cancer: evidence of increased drug activity in regionally infused tissues. Aust N Z J Surg 50:597-602
28. Edwards P, Blackshaw GR, Lewis WG, Barry JD, Allison MC, Jones DR (2004) Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer 90:1888-1892
29. Sierra A, Regueira FM, Hernandez-Lizoain JL, Pardo F, Martinez-Gonzalez MA, Cienfuegos JA (2003) Role of extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10:219-226
30. Ajani J, Mayer R, Ota D, Steele G, Evans D, Roh M (1993) Preoperative and postoperative chemotherapy for patients with potentially resectable gastric carcinoma. J Natl Cancer Inst 85:1839-1843
31. Cunliffe W, Sugarbaker P (1989) Gastrointestinal malignancy: Rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy (EPIC). Br J Surg 76:1082-1090
32. Eggermont A, Steller E, Sugarbaker P (1987) Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine activated killer cells. Surg 102:71-78
33. Sato M, Terashima M, Takagane A, Saito K, Okada Y, Oikawa K (1989) Clinical effectiveness of arterial infusion chemotherapy in advanced and recurrent gastric cancer. Gan To Kagaku Ryoho 16:2927-2931